With a much longer half-life than other radiotracers, flurpiridaz F-18 will boost patient access to PET imaging, one expert ...

GE HealthCare has secured the FDA’s approval for an injectable, radioactive imaging agent that gives clinicians a clearer ...

Called Flyrcado, the radiotracer could help improve cardiac imaging accuracy in patients with a high body mass index and women, the company said.

The FDA has approved a first-of-its-kind PET imaging agent for use in patients with suspected coronary artery disease.

The FDA has approved Flyrcado™ for positron emission tomography myocardial perfusion imaging under rest or stress in adult patients.

The injectable tracer, Flyrcado, could help doctors flag deadly coronary artery disease in patients during imaging tests.

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of ...

Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...

The NeuSight PET-CT is designed to revolutionize cardiac PET imaging, delivering superior value through its cutting-edge technology at an unmatched economics. With installations worldwide ...

Over the past two decades, India has witnessed a remarkable transformation in cardiac care, characterised by the rapid ...

Janey Godley shared the adorable moment she was reunited with her pet pooch Honey as she settled into life at a hospice where ...